$139.01
Value $768M
Mesa LaboratoriesvsRTX
MLAB and RTX stock compared: price, dividend, valuation and results, from SEC filings.
+2.82%
$198.58
Value $266B
Mesa Laboratories (MLAB) has a market value of $768M and RTX (RTX) $266B. Over the last year, with dividends, MLAB moved +75.1% and RTX +13.4%. The P/E is 115.2 for MLAB and 31.7 for RTX. Dividend yield: MLAB 0.46%, RTX 1.42%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MLAB$768M
RTX$266B
RTX is 347 times MLAB
Revenue, 12 months
MLAB$251M
RTX$96.0B
RTX is 382 times MLAB
Net income, 12 months
MLAB$6.7M
RTX$8.4B
RTX is 1,261 times MLAB
Operating margin
MLAB10.4%
RTX11.8%
1.4 points apart
ROIC
MLAB7.0%
RTX8.8%
1.7 points apart
P/E
MLAB115.2
RTX31.7
MLAB is 3.6 times RTX
Dividend yield
MLAB0.5%
RTX1.4%
0.9 points apart
5-year return
MLAB-54.5%
RTX+148.8%
203.3 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
MLAB-54.5%
RTX+148.8%
| Period | MLABWith dividends | RTXWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +75.1%Price +74.0% | +13.4%Price +11.8% |
| 3 years since November 13, 2023 | +67.6%+18.8% a yearPrice +64.4% | +157.0%+37.0% a yearPrice +142.1% |
| 5 years since November 12, 2021 | -54.5%-14.6% a yearPrice -55.7% | +148.8%+20.0% a yearPrice +123.5% |
| 10 years since November 15, 2016 | +15.2%+1.4% a yearPrice +10.3% | +268.0%+13.9% a yearPrice +193.0% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
MLABMesa LaboratoriesRTXRTX
Valuation
MLABRTX| Price | $139.01 | $198.58 |
|---|---|---|
| Market value | $768M | $266B |
| Enterprise value (EV) | – | $294B |
| P/E | 115.2 | 31.7 |
| P/E, 5-year median | – | 33.6 |
| P/B | 4.0 | 3.9 |
| EV/EBIT | – | 26.0 |
| Free cash flow yield | 6.4% | 3.6% |
Results and growth
MLABRTX| Revenue, 12 months | $251M | $96.0B |
|---|---|---|
| Net income, 12 months | $6.7M | $8.4B |
| Free cash flow, 12 months | $49M | $9.5B |
| Earnings per share, 12 months | $1.15 | $6.16 |
| Revenue growth, year on year | 3.4% | 9.7% |
| Revenue growth a year, past | +13.2%over 5 years | +9.4%over 5 years |
| EPS growth a year, past | +13.6%over 5 years | – |
Margins and returns on capital
MLABRTX| Gross margin | 64.8% | – |
|---|---|---|
| Operating margin | 10.4% | 11.8% |
| Net margin | 2.7% | 8.8% |
| ROIC | 7.0% | 8.8% |
| ROE | 3.6% | 12.7% |
Balance sheet
MLABRTX| Cash | $22M | $9.9B |
|---|---|---|
| Total debt | – | $38.9B |
| Net debt / EBITDA | – | 1.8 |
| Interest cover | 2.6× | – |
Dividends and buybacks
MLABRTX| Dividend yield | 0.5% | 1.4% |
|---|---|---|
| Dividend per share, 12 months | $0.64 | $2.82 |
| Dividend growth a year, past | +0.0%over 5 years | +4.3%over 5 years |
| Buyback yield | – | 0.0% |
| Shareholder yield | 0.5% | 1.4% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Mesa Laboratories or RTX?
By market value, RTX ($266B) is about 346.8 times Mesa Laboratories ($768M), at today's prices.
How did MLAB and RTX stock do over the last 10 years?
Since November 15, 2016, MLAB's price moved +10.3% and RTX's +193.0%. With dividends: MLAB +15.2% (+1.4% a year), RTX +268.0% (+13.9% a year). Past returns do not predict future ones.
Which pays the higher dividend, MLAB or RTX?
The dividend yield at today's price is 0.46% for Mesa Laboratories and 1.42% for RTX. Over the last twelve months they paid $0.64 and $2.82 per share.
What is the P/E of MLAB and RTX?
At today's price, the P/E is 115.2 for MLAB and 31.7 for RTX. It is the share price over the last twelve months' earnings per share.
Which has the higher profit margins, Mesa Laboratories or RTX?
Over the last twelve months, the net margin was 2.7% for Mesa Laboratories and 8.8% for RTX, and the operating margin 10.4% and 11.8%. Revenue was $251M and $96.0B.
Which is the better investment, Mesa Laboratories or RTX?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.